Proactive - FDA EFS Approval PCR LV Panel Discussion – Nov 22 TCT MD Panel Discussion – Sept 22 News 9, Interview with Anteris

DECK - PCR London Valves: Late Breaking Clinical Trial DECK - PCR London Valves: Rapid Fire Abstract VIDEO - 2022 Annual General Meeting VIDEO - Live in the OR

We are pleased to announce Perceptive Life Sciences has invested USD 20 million into Anteris - 2 Mar 2022 Anteris Technologies tapped for merger with 'blank check' NASDAQ-lister - 10 Feb 2022 Anteris Technologies' 30-day data from in-human heart valve trial yields promising results - 25 Jan 2022 Anteris Reports Successful Interim Results for the First-in-Human Trial for DurAVR - 24 Jan 2022 CEO Magazine - Spotting Opportunities Top 10 MedTech Startup